Chalazia associated with bortezomib therapy for multiple myeloma

Ophthalmology. 2014 Sep;121(9):1845-7.e3. doi: 10.1016/j.ophtha.2014.04.021. Epub 2014 Jun 25.

Authors

Seanna R Grob¹, Frederick A Jakobiec², Alia Rashid², Michael K Yoon¹

Affiliations

¹ Ophthalmic Plastic Surgery, Massachusetts Eye and Ear Infirmary, Boston, Massachusetts; Department of Ophthalmology, Harvard Medical School, Boston, Massachusetts.
² David G. Cogan Ophthalmic Pathology Laboratory, Massachusetts Eye and Ear Infirmary, Boston, Massachusetts; Department of Ophthalmology, Harvard Medical School, Boston, Massachusetts.

PMID: 24974380
DOI: 10.1016/j.ophtha.2014.04.021

No abstract available

MeSH terms

Aged
Antineoplastic Agents / adverse effects*
Boronic Acids / adverse effects*
Bortezomib
Chalazion / chemically induced*
Chalazion / pathology
Female
Humans
Male
Middle Aged
Multiple Myeloma / drug therapy*
Pyrazines / adverse effects*
Retrospective Studies

Substances

Antineoplastic Agents
Boronic Acids
Pyrazines
Bortezomib